内镜超声检查对胆总管扩张的诊断价值

目的评价内镜超声检查(EUS)对胆总管扩张的病因诊断价值。方法32例患者在EUS 前均做过体表B超检查。患者的病因诊断均在病理或手术(包括奥狄括约肌切开取石)后确定。结果(1)32例患者的B超及EUS对胆总管直径的测定结果分别为(1.04±0.41)cm和(0.97±0.36)cm,两者差异无显著性(P＞0.05)。(2)对胆总管扩张的病因诊断率EUS为29/32(90.6％),明显高于体表B超19/32(59.4％),P＜0.01;X线电子计算机断层扫描(CT)21/32(65.6％),P＜0.05。EUS与磁共振胆胰管成像(MRCP)13/16(81.3％)和内镜逆行胰胆管造影(ERCP)31/32(96.9％)诊断率 相似(P＞0.05)。结论EUS对胆总管扩张的病因有很高的诊断价值。     

内镜超声检查对胆总管无扩张伴可疑胆总管结石的诊断价值

目的 探讨胆总管无扩张伴可疑胆总管结石患者（CBDS）行超声内镜检查（EUS）的价值.方法 对33例经多次腹部B超检查诊断胆囊结石,胆总管直径〈8 mm,未发现CBDS但有急性胰腺炎、阻塞性黄疸或反复胆绞痛等病史之一的患者行EUS,并与手术或ERCP结果进行比较.结果 33例患者行EUS,20例发现CBDS.经进一步手术或ERCP,该20例患者中有16例证实有CBDS.EUS对本组病例CBDS诊断的灵敏度为100%,特异度为76.5%,阳性预测价值为80%,阴性预测价值为100%.结论 对胆总管无扩张但有可疑CBDS者行EUS检查有较高的临床价值.     

内镜超声检查对胆总管扩张的诊断价值

目的 探讨内镜超超检查（ｅｎｄｏｓｃｏｐｉｃ ｕｌｔｒａｓｏｎｏｇｒａｐｈｙ,ＥＵＳ）对不明原因的胆总管扩张的诊断和鉴别诊断价值。方法 对４３例经多次腹部Ｂ超检查未能明确病因诊断的胆总管扩张患者行ＥＵＳ,并与手术和病理结果进行比较。结果 ＥＵＳ诊断为胆总管结石３４例,胰头占位性病变５例,胆道系统肿瘤２例,先天性胆道扩张１例。ＥＵＳ检查阳性率９７．７％,与手术和病理对照正确率为８８．４％。结论 ＥＵ     

胆总管结石的内镜超声诊断

胆总管结石 (ｃｏｍｍｏｎｂｉｌｅｄｕｃｔｓｔｏｎｅ,ＣＢＤＳ)由于解剖部位特殊 ,常不易用常规方法诊断。我们为 42例经反复多次上腹部Ｂ型超声波检查 (ｔｒａｎｓａｂｄｏｍｉｎａｌｕｌｔｒａｓｏｎｏｇｒａｐｈｙ ,ＵＳ)未能发现ＣＢＤＳ的患者进行了内镜超声检查技术 (ｅｎｄｏｓｃｏｐｉｃｕｌｔｒａｓｏｎｏｇｒａｐｈｙ ,ＥＵＳ) ,并同ＥＲＣＰ和手术结果对比研究。现将ＥＵＳ在ＣＢＤＳ患者诊断中的应用体会作一分析讨论。材料和方法一、研究对象42例患者均系 1998年 11月至 2 0 0 0年 3月期间我院门诊和住院患者。男 2 2例 ,女 …     

超声内镜诊断胆总管结石的临床价值分析

目的比较超声内镜（EUS）与B型超声波（US）、CT、磁共振胰胆管成像（MRCP）、内镜逆行胰胆管造影（ERCP）诊断胆总管结石的临床价值。方法对经手术及病理证实的96例胆总管结石患者的EUS、US、CT、MRCP、ERCP检查进行回顾性分析,比较其诊断胆总管结石的敏感性、特异性、阳性预测值（PPV）、阴性预测值（NPV）及准确率。结果 EUS诊断敏感性、特异性、PPV、NPV及准确率均显著高于US（P〈0.05）,敏感性和准确率均显著高于CT（P〈0.05）,各项诊断指标与MRCP和ERCP比较无显著差异。结论 EUS诊断胆总管结石具有准确性和安全性高等优点,与US、CT、MRCP及ERCP相比具有一定优势。     

超声内镜对胆总管小结石的诊断价值

为评估超声内镜检查术（endoscopic ultrasonography,EUS）对胆总管小结石的诊断价值,纳入2018年1月—2021年7月在东南大学附属中大医院住院并诊断为可疑胆总管结石的患者60例。所有患者于同一次住院期间行EUS及磁共振胰胆管成像（magnetic resonance cholangiopancreatography,MRCP）。以经内镜逆行胰胆管造影、开腹探查或腹腔镜胆总管探查结果为金标准,比较EUS及MRCP对胆总管结石的诊断结果,计算2种检查方法的灵敏度、特异度、阳性预测值、阴性预测值。结果显示,60例患者中46例确诊胆总管结石,EUS诊断准确43例,MRCP诊断准确35例;14例患者证实胆总管结石阴性,EUS诊断准确12例,MRCP诊断准确13例。EUS诊断灵敏度明显高于MRCP［93.48%（43/46）比76.09%（35/46）,χ2=4.128,P=0.042］。结石直径≤1.0 cm者45例,其中EUS确诊42例,MRCP确诊34例（诊断准确率93.33%比75.56%,χ2=4.145,P=0.042）;直径≤0.8 cm者39例,其中EUS确诊36例,MRCP确诊28例（诊断准确率92.31%比71.79%,χ2=4.266,P=0.039）;直径≤0.5 cm者26例,其中EUS确诊24例,MRCP确诊16例（诊断准确率92.31%比61.54%,χ2=5.038,P=0.021）。在胆总管结石的诊断方面,EUS有明显的诊断优势,且诊断准确性不受结石大小的影响,因此对于临床高度怀疑胆总管结石但MRCP结果阴性的患者,需进一步行EUS。     

内镜超声检查对胆总管扩张的诊断价值

胆总管扩张是由多种因素引起的征象。患通常有右上腹痛、不适,伴黄疸或不伴黄疸。部分病例在体表B超检查时发现胆总管扩张：患往往需要作上腹部X线电子计算机断层扫描(CT)、内镜逆行胰胆管造影(ERCP)、磁共振胆胰管成像(MRCP)及血管造影等项检查,以明确胆总管扩张的病因。近年来胆胰内镜超声检查(EUS)技术的发展已越来越为人们所瞩目。     

超声内镜诊断胆总管微结石的价值分析

目的 分析胆总管微结石诊断中超声内镜的价值.方法 回顾性选取2017年1月至2019年12月中山市人民医院消化内科疑似胆总管结石患者80例,均接受腹部超声、超声内镜及内镜逆行胰胆管造影或手术病理检查,对比腹部超声检查、超声内镜检查与内镜逆行胰胆管造影或手术病理检查结果,统计分析腹部超声检查与超声内镜检查结果及其对不同直...     

超声内镜对核磁共振胰胆管造影术阴性胆总管结石的诊断价值

[目的]探讨超声内镜(endoscopic ultrasonography,EUS)对核磁共振胰胆管造影术(magnetic resonance cholangiopancreatography,MRCP)显示阴性的胆总管结石的诊断价值。[方法]回顾性分析完善EUS、MRCP两项检查诊断为胆总管结石81例患者的临床资料。通过SPSS统计学方法、χ~2检验对比分析两项检查方法对胆总管结石的诊断差别,研究EUS对MRCP显示阴性的胆总管结石的影像特征及临床价值。以内镜逆行胰胆管造影术取出结石或采用Seldinger's技术经穿刺道取出结石、经T管胆道镜取出结石为金标准。[结果]81例均经临床治疗取出结石。EUS、MRCP对该81例胆总管结石的检出率分别为90.1%(73/81)、79.0%(64/81),差异有统计学意义(χ~2=9.225,P0.01)。经对EUS诊断为阳性、而MRCP诊断为阴性的12例患者基本信息分析表明,EUS对扩张胆总管的诊断高于MRCP,但二者对扩张胆总管最大直径的测量比较差异无统计学意义(P0.05)。[结论]EUS对胆总管结石的诊断优于MRCP,尤其对MRCP显示阴性的胆总管结石有独特的优势;二者对于扩张胆总管直径的测量,无显著差异。     

胆总管腺瘤的内镜超声表现

目的:探讨胆总管腺瘤的内镜超声(endoscopic ultrasonography, EUS)下特征性表现。方法:回顾性研究2015年1月—2020年1月天津市南开医院收治的经病理证实的15例胆总管腺瘤患者的临床资料,对其EUS特点进行总结分析。结果:胆总管腺瘤EUS下表现为均质中等或中低回声软组织团块,边界清晰,动...     

Poorly expandable common bile duct with stones on endoscopic retrograde cholangiography

AIM: To describe characteristics of a poorly expandable (PE) common bile duct (CBD) with stones on endoscopic retrograde cholangiography.METHODS: A PE bile duct was characterized by a rigid and relatively narrowed distal CBD with retrograde dilatation of the non-PE segment. Between 2003 and 2006, endoscopic retrograde cholangiography (ERC) images and chart reviews of 1213 patients with newly diagnosed CBD stones were obtained from the computer database of Therapeutic Endoscopic Center in Chang Gung Memorial Hospital. Patients with characteristic PE bile duct on ERC were identified from the database. Data of the patients as well as the safety and technical success of therapeutic ERC were collected and analyzed retrospectively.RESULTS: A total of 30 patients with CBD stones and characteristic PE segments were enrolled in this study. The median patient age was 45 years (range, 20 to 92 years); 66.7% of the patients were men. The diameters of the widest non-PE CBD segment, the PE segment, and the largest stone were 14.3 ± 4.9 mm, 5.8 ± 1.6 mm, and 11.2 ± 4.7 mm, respectively. The length of the PE segment was 39.7 ± 15.4 mm (range, 12.3 mm to 70.9 mm). To remove the CBD stone(s) completely, mechanical lithotripsy was required in 25 (83.3%) patients even though the stone size was not as large as were the difficult stones that have been described in the literature. The stone size and stone/PE segment diameter ratio were associated with the need for lithotripsy. Post-ERC complications occurred in 4 cases: pancreatitis in 1, cholangitis in 2, and an impacted Dormia basket with cholangitis in 1. Two (6.7%) of the 28 patients developed recurrent CBD stones at follow-up (50 ± 14 mo) and were successfully managed with therapeutic ERC.CONCLUSION: Patients with a PE duct frequently require mechanical lithotripsy for stones extraction. To retrieve stones successfully and avoid complications, these patients should be identified during ERC.     

经十二指肠镜括约肌切开胆总管结石的处理(附168例报告)

目的：采用各种方法处理不同大小的胆总管结石。方法：于1986年3月至1996年9月经内镜括约肌切开（EST）治疗胆总管结石168例，其中单颗结石63例，2颗结石56例，3颗以上结石49例，最多一例8颗结石，结石的直径为5～25mm不等。结果：165例（98．2％）切开成功，3例失败。161例（95．8％）结石排出，其中96例（59．6％）结石自然排入肠道，57例（35．4％）采用网篮或气囊取出结石，6例（3．7％）采用碎石网篮碎石后排出，2例（1．2％）经震波碎石后排出。术后出现胃肠道出血1例（0．6％），胰腺炎1例（0．6％），胆管炎3例（1．8％）。48例术后行胃肠钡餐检查，43例胆道内无钡剂返流，2例胆道内有积气，3例有钡剂返流入胆道，但无临床症状。结论：EST是目前治疗胆管结石的重要手段之一。     

Reappraisal of endoscopic papillary balloon dilation for the management of common bile duct stones

Although endoscopic sphincterotomy(EST) is still considered as a gold standard treatment for common bile duct(CBD) stones in western guideline, endoscopic papillary balloon dilation(EPBD) is commonly used by the endoscopists in Asia as the first-line treatment for CBD stones. Besides the advantages of a technical easy procedure, endoscopic papillary large balloon dilation(EPLBD) can facilitate the removal of large CBD stones.The indication of EPBD is now extended from removal of the small stones by using traditional balloon, to removal of large stones and avoidance of lithotripsy by using large balloon alone or after EST. According to the reports of antegrade papillary balloon dilatation, balloon dilation itself is not the cause of pancreatitis. On the contrary, adequate dilation of papillary orifice can reduce the trauma to the papilla and pancreas by the basket or lithotripter during the procedure of stone extraction. EPLBD alone is as effective as EPLBD with limited EST. Longer ballooning time may be beneficial in EPLBD alone to achieve adequate loosening of papillary orifice. The longer ballooning time does not increase the risk of pancreatitis but may reduce the bleeding episodes in patients with coagulopathy. Slowly inflation of the balloon, but not exceed the diameter of bile duct and tolerance of the patients are important to prevent the complication of perforation. EPBLD alone or with EST are not the sphincter preserved procedures, regular follow up is necessary for early detection and management of CBD stones recurrence.     

Using cholecystokinin to facilitate endoscopic clearance of large common bile duct stones

AIM:To evaluate the effect of cholecystokinin(CCK)during extracorporeal shockwave lithotripsy(ESWL)in the clearance of common bile duct(CBD)stones in endoscopic retrograde cholangiopancreatography(ERCP).METHODS:Between January 2007 and September2012,patients with large CBD stones who were treated with ESWL and ERCP were identified retrospectively.Patients were randomized in equal numbers to cholecystokinin(CCK)and no CCK groups.For each CCK case,a dose(3 ng/kg per min for 10 min)of sulfated octapeptide of CCK-8 was administered intravenously near the beginning of ESWL.ERCP was performed 4 h after a session of ESWL.The clearance rate of the CBD was assessed between the two groups.RESULTS:A total of 148 consecutive cases(CCK group:74,no CCK group:74)were tallied.Overall there were 234 ESWLs and 228 ERCPs in the 148 cases.The use of CCK showed a significantly higher rate of successful stone removal in the first ESWL/ERCP procedure(71.6%vs 55.4%,P=0.035),but resulted in similar outcomes in the second(42.8%vs 39.4%)and third(41.7%vs 40.0%)sessions,as well as total stone clearance(90.5%vs 83.8%).The use of mechanical lithotripsy was reduced in the CCK group(6.8%vs17.6%,P=0.023),and extremely large stone(≥30mm)removal was higher in the CCK group(72.7%vs41.7%,P=0.038).CONCLUSION:CCK during ESWL can aid with the clearance of CBD stones in the first ESWL/ERCP session.Mechanical lithotripsy usage was reduced and the extremely large stone(≥30 mm)clearance rate can be raised.     

胆管腔内超声与逆行胆管造影诊断胆管结石的对比研究

目的 比较十二指肠镜下胆管腔内超声（IDUS）和内镜下逆行胆管造影（ERC）诊断肝外胆管结石的作用。方法 对30例临床怀疑有肝外胆管结石的患者，先进行ERC，再经内镜活检孔道将超声微探头直接送入胆管腔内探查，而后行乳头切开取石。结果 30例患者中，ERC准确诊断结石26例，将胆管絮状物诊断为结石1例，漏诊2例，其诊断结石的准确率，敏感性分别为86.7%(26/30),92.9%(26/28)；而IDUS准确诊断结石28例，无漏诊，误诊，其诊断结石的准确率，敏感性均为100.0%。结论 IDUS可弥补ERC的视觉误差且在确定胆管结石方面优于ERC。     

Composition of common bile duct stones in Chinese patients during and after endoscopic sphincterotomy

AIM: Endoscopic sphincterotomy (ES) is a well-established therapeutic modality for the removal of common bile duct (CBD) stones. After ES there are still around 10% of patients that experience recurrent CBD stones. The aim of this study is to investigate the composition of CBD stones before and after ES and its clinical significance in Chinese patients. METHODS: From January 1996 to December 2003, 735 patients with CBD stones received ES at Kaohsiung Veterans General Hospital and stone specimens from 266 patients were sent for analysis. Seventy-five patients had recurrent CBD stones and stone specimens from 44 patients were sent for analysis. The composition of the stones was analyzed by infrared (IR) spectrometry and they were classified as cholesterol or bilirubinate stones according to the predominant composition. Clinical data were analyzed. RESULTS: In the initial 266 stone samples, 217 (82%) were bilirubinate stones, 42 (16%) were cholesterol stones, 3 were calcium carbonate stones, 4 were mixed cholesterol and bilirubinate stones. Patients with bilirubinate stones were significantly older than patients with cholesterol stones (66±13 years vs56±17 years, P= 0.001). In the 44 recurrent stone samples, 38 (86%) were bilirubinate stones, 3 (7%) were cholesterol stones, and 3 were mixed cholesterol and bilirubinate stones. In 27 patients, both initial and recurrent stone specimens can be obtained, 23 patients had bilirubinate stones initially and 2 became cholesterol stones in the recurrent attack. In the four patients with initial cholesterol stones, three patients had bilirubinate stones and one patient had a cholesterol stone in the recurrent attack. CONCLUSION: Bilirubinate stone is the predominant composition of initial or recurrent CBD stone in Chinese patients. The composition of CBD stones may be different from initial stones after ES.     

Outcomes of endoscopic sphincterotomy vs open choledochotomy for common bile duct stones

BACKGROUND Endoscopic sphincterotomy(EST) for the management of common bile duct stones(CBDS) is used increasingly widely because it is a minimally invasive procedure. However, some clinical practitioners argued that EST may be complicated by post-endoscopic retrograde cholangiopancreatography(ERCP)pancreatitis(PEP) and accompanied by a higher recurrence of CBDS than open choledochotomy(OCT). Whether any differences in outcomes exist between these two approaches for treating CBDS has not been thoroughly elucidated to date.AIM To compare the outcomes of EST vs OCT for the management of CBDS and to clarify the risk factors associated with stone recurrence.METHODS Patients who underwent EST or OCT for CBDS between January 2010 and December 2012 were enrolled in this retrospective study. Follow-up data were obtained through telephone or by searching the medical records. Statistical analysis was carried out for 302 patients who had a follow-up period of at least 5 years or had a recurrence. Propensity score matching(1:1) was performed to adjust for clinical differences. A logistic regression model was used to identify potential risk factors for recurrence, and a receiver operating characteristic(ROC)curve was generated for qualifying independent risk factors.RESULTS In total, 302 patients undergoing successful EST(n = 168) or OCT(n = 134) were enrolled in the study and were followed for a median of 6.3 years. After propensity score matching, 176 patients remained, and all covariates were balanced. EST was associated with significantly shorter time to relieving biliary obstruction, anesthetic duration, procedure time, and hospital stay than OCT(P <0.001). The number of complete stone clearance sessions increased significantly in the EST group(P = 0.009). The overall incidence of complications and mortality did not differ significantly between the two groups. Recurrent CBDS occurred in18.8%(33/176) of the patients overall, but no difference was found between the EST(20.5%, 18/88) and OCT(17.0%, 15/88) groups. Factors associated with CBDS recurrence included common bile duct(CBD) diameter > 15 mm(OR =2.72; 95%CI: 1.26-5.87; P = 0.011), multiple CBDS(OR = 5.09; 95%CI: 2.58-10.07; P< 0.001), and distal CBD angle ≤ 145°(OR = 2.92; 95%CI: 1.54-5.55; P = 0.001). The prediction model incorporating these factors demonstrated an area under the receiver operating characteristic curve of 0.81(95%CI: 0.76-0.87).CONCLUSION EST is superior to OCT with regard to time to biliary obstruction relief, anesthetic duration, procedure time, and hospital stay and is not associated with an increased recurrence rate or mortality compared with OCT in the management of CBDS.